Vascular Web Logo

SVS  SVS Foundation
A A A
VascularWeb

 Saturday, June 9, 2012


All events occur at the Gaylord National Resort & Convention Center, unless otherwise noted. Schedule is subject to change.

6:00 am – 5:30 pm           Registration
                                        Room: Level 1 Foyer

6:30 am – 8:00 am           BREAKFAST SESSIONS

B7: SVS: A Meeting with Leaders for the Future of Our Specialty
Room: Maryland A

At the end of this session, participants should be able to: 

  1. Discuss the current goals and purpose of the SVS.
  2. Describe the nature and function of committees and councils of the organization.
  3. Discuss new SVS initiatives in practice, education and research.
  4. Identify where there are areas of interest for members to become involved.

Moderators: Peter Gloviczki MD, Mayo Clinic, Rochester, MN
Julie Ann Freischlag MD, Johns Hopkins University School of Medicine, Baltimore, MD

6:30 am
The SVS Organization: Purpose and Goals
Richard P. Cambria MD, Massachusetts General Hospital, Boston, MA

6:40 am
How the SVS Works
Peter Gloviczki MD, Mayo Clinic, Rochester, MN

6:50 am
Fellows Council
Rodney A. White MD, Harbor UCLA, Los Angeles, CA

7:00 am
Education Council
John F. Eidt MD, University of Arkansas for Medical Sciences, Little Rock, AR

7:10 am
Research Council
Larry W. Kraiss MD, University of Utah Medical Center, Salk Lake City, UT

7:20 am
Clinical Practice Council
Ruth L. Bush MD, Scott and White Memorial Hospital, Temple, TX

7:30 am
Panel Discussion

B8: How Current Federal Initiatives May Fundamentally Change Surgical Practice
Room: Maryland C

At the end of this session, participants should be able to:

  1. Explain why the Washington office is a vital part of SVS.
  2. Describe PPACA, the health care reform law.
  3. Review potential new ways to practice such as Accountable Care Organizations and bundling vs. fee for service.
  4. Discuss the potential threat to private practitioners and their patients.
  5. Discuss the history and possible permanent solution to the SGR formula that determines Medicare pay for physicians.
Moderators: Carlo A. Dall'Olmo MD, Michigan Vascular Center, Flint, MI
Pamela Phillips, Society for Vascular Surgery, Washington, DC
 
6:30 am
Introduction/Explanation of the SVS Washington Office
Pamela Phillips, Society for Vascular Surgery, Washington, DC
 
6:40 am
Overview of PPACA and Its Impact upon Vascular Surgeons
Jill Rathbun, Galileo Consulting Group, Arlington, VA
 
6:50 am
Current and Upcoming CMS Initiatives
Margaret C. Tracci MD, University of Virginia Health System Vascular Center, Charlottesville, VA
 
7:00 am
Impact of Health Care Reform on Vascular Surgery Practices and Patient Care
Carlo A. Dall’Olmo MD, Michigan Vascular Center, Flint, MI
 
7:10 am
Medicare Physician Payment and the SGR Formula
Robert M. Zwolak MD PhD, Dartmouth-Hitchcock Medical Center, Lebanon, NH
 
7:20 am
Panel Discussion
 
B9: Controversies in TEVAR
Room: Maryland D
 
At the end of this session, participants should be able to:
  1. Describe the indications for revascularization of the left subclavian artery when performing endovascular repair of descending thoracic aortic aneurysms.
  2. Explain the role of medical therapy and endovascular repair for the treatment of acute uncomplicated Type B dissection.
  3. Explain the role of hybrid aortic arch debranching procedures and complex branched grafts, fenestrations and chimneys in the treatment of Aortic arch aneurysms.

Moderators: Christopher J. Kwolek MD, Massachusetts General Hospital, Boston, MA
Mark A. Farber MD, University of North Carolina Hospitals, Chapel Hill, NC

6:30 am
Coverage of the Left Subclavian Artery for TEVAR Should Always Be Preceded By Carotid-Subclavian Bypass or Its Endovascular Equivalent
Adam W. Beck MD, University of Florida, Gainesville, FL

6:40 am
A Selective Approach to Carotid-Subclavian Bypass is Best When Performing TEVAR
Jose Trani, Jr. MD, Cooper University Hospital, Camden, NJ

6:50 am
Discussion

7:00 am
Early Stent Graft Repair Should be the Treatment of Choice for Uncomplicated Type B Dissection
Tara M. Mastracci MD, The Cleveland Clinic, Cleveland, OH

7:10 am
Medical Therapy is Still the Preferred Treatment Unless Complications Arise
Ali Azizzadeh MD, University of Texas Medical School, Houston, TX

7:20 am
Discussion

7:30am
Total Endovascular Repair (Selected Chimney, In Situ Fenestrations and Branched Stent Grafts) is Superior to Hybrid Approach for Arch Repair
Gustavo Oderich MD, Mayo Clinic, Rochester, MN

7:40 am
Hybrid Debranching is a Better Option for Revascularizing the Arch Vessels
Virendra I. Patel MD, Massachusetts General Hospital, Boston, MA

7:50 am
Discussion

6:30 am – 8:00 am            Women’s Leadership Roundtable*
                                         Room: Potomac C

The SVS Women's Leadership Committee will host a roundtable discussion with women leaders in academic medicine, health care, and the government. Discussion topics include identifying the characteristics or qualities of good leaders, finding strong role models, recognizing unique or major challenges for women seeking leadership roles, and the mentorship of young women to become the leaders of tomorrow.

Moderator: Eva Rzucidlo MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH


Panelists: Dorothy Abel, Food and Drug Administration, Silver Spring, MD
Kellie Brown MD, Medical College of Wisconsin, Milwaukee, WI
Terri Kelly, W. L. Gore & Associates, Inc., Newark, DE
Robyn Macasta MD, Georgetown/Washington Hospital Center, Washington, D.C
Amy Reed MD, Penn State Heart and Vascular Institute, Hershey, PA
Additional panelists to be announced onsite.

*This program is not eligible for CME credit.

8:00 am – 9:30 am            S6: SVS Plenary Session VI
                                         Room: Potomac A/B

At the end of this session, participants should be able to:
  1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
  2. Identify new technology for diagnosis and treatment of vascular disease.
Moderators: R. Clement Darling, III MD, The Vascular Group, Albany, NY
Eva M. Rzucidlo MD, Dartmouth-Hitchcock Medical Center, Lebanon, NH

8:00 am
SS25. The Influence of Contralateral Occlusion on Results of Carotid Interventions from the Society for Vascular Surgery (SVS) Vascular Registry™
Joseph J. Ricotta1, Gilbert R. Upchurch2, Gregg S. Landis3, Christopher T. Kenwood4, Flora S. Siami4, John J. Ricotta5, Rodney A. White6
1Emory University School of Medicine, Atlanta, GA; 2University of Virginia, Charlottesville, VA; 3New York Hospital Queens, New York, NY; 4New England Research Institutes, Inc., Watertown, MA; 5Washington Hospital Center, Washington, DC; 6Harbor UCLA, Los Angeles, CA.

8:14 am
SS26. Improving Patient Selection for Carotid Endarterectomy in Asymptomatic Patients Based on Predicted 5-year Survival
Jessica B. Wallaert1, Jack L. Cronenwett1, Daniel J. Bertges2, Andres Schanzer3, Randall R. De Martino1, Brian W. Nolan1, Jens Eldrup-Jorgensen4, Philip P. Goodney1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH; 2Fletcher Allen Health Care, Burlington, VT; 3UMass Memorial Health Care, Worcester, MA; 4Maine Medical Center, Portland, ME.

8:28 am
Video Presentation
VS7. Complex Carotid Reconstruction: Left Subclavian to Carotid Bypass with Branched Grafts to the Left Vertebral and Carotid Arteries
Jacob Quick, Colleen S. Hupp, Rumi Faizer
University of Missouri, Columbia, MO.

8:38 am
SS27. The Risk of Carotid Artery Stenting Compared with Carotid Endarterectomy is Greatest in Patients Treated Within 7 Days of Symptoms
Barbara Rantner1, Georg Goebel2, Leo Bonati3, Gustav Fraedrich1
1Department of Vascular Surgery, Innsbruck Medical University, Innsbruck, Austria; 2Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria; 3Department of Neurology and Stroke Unit, University Hospital Basel, Basel, Switzerland.

8:52 am
SS28. The Size of Juxtaluminal Black Area in Ultrasonic Images of Asymptomatic Carotid Plaques Predicts the Occurrence of Stroke
Stavros K. Kakkos, Maura B. Griffin, Andrew N. Nicolaides, Efthyvoulos C. Kyriacou, Michael M. Sabetai, Thomas J. Tegos, George Geroulakos
Imperial College, London, London, United Kingdom.

9:06 am
SS29. The Hemodynamic Impact of Balloon Angioplasty in Multiple Sclerosis Patients with Chronic Cerebrospinal Venous Insufficiency
Manish Mehta, R. Clement Darling, Sean P. Roddy, Paul B. Kreienberg, John B. Taggert, Kathleen J. Ozsvath, Jorge Rey, Dhiraj M. Shah
The Institute for Vascular Health and Disease, Albany Medical College/Albany Medical Center Hospital, Albany, NY.

9:00 am – 1:00 pm            Exhibit Hall Open
                                         Room: Exhibit Halls A-C

9:30 am – 10:00 am          Coffee Break
                                         Room: Exhibit Halls A-C

10:00 am – 11:00 am        F2:  Vascular Surgeon’s Adoption To New Technology Arrivals In 2012-2013
                                         Room: Potomac A/B

At the end of this session, participants should be able to:

  1. Describe the technical aspects of the new low profile abdominal aortic stent grafts, along with the current clinical data.
  2. Describe the technical aspects of the fenestrated abdominal aortic stent grafts, along with the current clinical data.
  3. Discuss the various new devices available to facilitate proximal fixation during EVAR.
  4. Discuss the various new thoracic stent grafts available to facilitate treatment of thoracic aortic dissections and traumatic disruptions.
  5. Explain the implications of new flow reversal cerebral protection devices, along with the current clinical data.
  6. Describe the current data supporting the use of drug eluting stents for treatment of SFA and Popliteal artery occlusive disease.
  7. Discuss the on-label indications for use of currently available iliac and SFA stents and stent grafts.
  8. Explain the benefits of new infrainguinal CTO devices and techniques.
  9. Explain the benefits and indications for new devices for venous ablation.
  10. Discuss the emergence of new retrievable IVC filters and their pros and cons. 
Moderators: Manish Mehta MD, The Institute for Vascular Health & Disease, Albany, NY
James F. McKinsey MD, New York-Presbyterian Hospital, Columbia University, New York, NY
 
10:00 am
The Emergence of Low Profile EVAR Devices
Manish Mehta MD, The Institute for Vascular Health & Disease, Albany, NY
 
10:05 am
Tackling Complex Aortic Necks with Fenestrated Stent Grafts
James F. McKinsey MD, New York-Presbyterian Hospital, Columbia University, New York, NY
 
10:10 am
Will the Aptus Endostaple Replace The Palmaz Stent During EVAR?
William D. Jordan Jr. MD, University of Alabama at Birmingham, Birmingham, AL
 
10:15 am
TEVAR Beyond Aneurysm Repair
Mark A. Farber MD, University of North Carolina Hospitals, Chapel Hill, NC
 
10:20 am
Flow Reversal with Carotid Cutdown, A Game Changer For Carotid Stenting
Christopher J. Kwolek MD, Massachusetts General Hospital, Boston, MA
 
10:25 am
The Impact of Drug Eluting Stents in the SFA
Sean P. Lyden MD, The Cleveland Clinic Foundation, Cleveland, OH
 
10:30 am
The Emergence of On-Lable Iliac and SFA Stents and Stent Grafts
Daniel G. Clair MD, The Cleveland Clinic, Cleveland, OH
 
10:35 am
Improvements in CTO Technology and Techniques
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI
 
10:40 am
Advances in Venous Ablation
Steve M. Elias MD, New York-Presbyterian Hospital, Columbia University, New York, NY
 
10:45 am
What’s New and Different about Retrievable IVC Filters
Anthony J. Comerota MD, Jobst Vascular Center, Toledo, OH
 
10:50 am
Panel Discussion
11:00 am – Noon             F3: Poster Runoff: Championship Round
                                        Room: Potomac A/B
Moderator: Peter F. Lawrence MD, UCLA Medical Center, Los Angeles, CA
Judges: Richard P. Cambria MD, Massachusetts General Hospital, Boston, MA
Peter Gloviczki MD, Mayo Clinic, Rochester, MN
Noon – 12:50 pm             Lunch in Exhibit Hall
                                        Room: Exhibit Halls A-C
 
Noon – 12:50 pm             Vascular Surgery Trainee Section Luncheon
                                        Room: National Harbor 10
                                         
12:50 pm – 1:30 pm         Guest Speaker: Joseph M. Giordano MD
                                        Rawhide Down: An Historical Perspective
                                        Room: Potomac A/B
 
1:30 pm – 2:35 pm           R1: Rapid Paced Paper Session I
                                        Room: Potomac A/B
At the end of this session, participants should be able to:
  1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
  2. Identify new technology for diagnosis and treatment of vascular disease.
Moderators: Peter Gloviczki MD, Mayo Clinic, Rochester, MN
Robert Y. Rhee MD, Lutheran Medical Center, Brooklyn, NY

1:30 pm
RR1. Safety of Carotid Stenting (CAS) is Based on the Center Experience More than on the Individual Performance
Gianbattista Parlani1, Paola De Rango1, Fabio Verzini1, Enrico Cieri1, Gioele Simonte1, Piergiorgio Cao2
1Vascular and Endovascular Surgery; University of Perugia, Perugia, Italy; 2Vascular Surgery, Hospital S.Camillo Forlanini, Rome, Italy.

1:33 pm
RR2. The Influence of Gender on Functional Outcomes of Lower Extremity Bypass
Reshma B. Patel1, Daniel J. Bertges1, Peter Callas1, Andres Schanzer2, Philip P. Goodney3, Michael A. Ricci1, Jack L. Cronenwett3, Andrew C. Stanley1, Julie E. Adams1, For the Vascular Surgery Group of New England
1University of Vermont College of Medicine, Burlington, VT; 2University of Massachusetts Medical School, Worchester, MA; 3Dartmouth-Hitchcock Medical School, Lebanon, NH.

1:36 pm
RR3. Protamine Sulfate Use Does Not Lower Hemorrhagic Complications in Lower Extremity Bypass (LEB)
James T. McPhee, Karen J. Ho, Joseph Lopez, Robert Glynn, Michael Belkin, Matthew T. Menard
Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA.

1:39 pm
RR4. Predictive Factors of 30-day Unplanned Readmission (URA) After Lower Extremity Bypass (LEB)
James T. McPhee1, Neal R. Barshes2, Karen J. Ho1, Arin Madenci1, Charles K. Ozaki1, Louis L. Nguyen1, Michael Belkin1
1Vascular and Endovascular Surgery, Brigham and Women's Hospital, Boston, MA; 2Michael E. DeBakey VA Medical Center, Houston, TX.

1:42 pm
RR5. Surgical Treatment of Popliteal Aneurysms Using a Posterior Approach: Thirteen Years’ Follow-up
Daniela Mazzaccaro1, Michele Carmo1, Giovanni Grava1, Alberto M. Settembrini1, Raffaello Dallatana1, Iacopo Barbetta1, Piergiorgio Settembrini2
1Division of Vascular Surgery S.Carlo Borromeo Hospital, Milan, Italy; 2Università degli Studi di Milano, Milan, Italy.

1:45 pm
Discussion: RR1, RR2, RR3, RR4, RR5

1:55 pm
RR6. The Use of Reentry Devices Improves the Technical Success, Safety, and Patency of Recanalization of Chronic Total Occlusions of the Iliac Arteries
Sadaf S. Ahanchi, Brian Chen, Samuel Steerman, Richard Redlinger, Jean M. Panneton
Department of Surgery Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA.

1:58 pm
RR7. Improving Patient Selection for Limb Salvage vs. Early BKA
Benjamin J. Brown1, Matthew L. Iorio1, Mitch Klement1, Michael R. Conti Mica1, Amine El-Amraoui1, Peter O'Halloran1, Richard F. Neville2, Christopher E. Attinger1
1Plastic Surgery, Georgetown University, Washington, DC; 2George Washington University, Washington DC.

2:01 pm
RR8. Directional Atherectomy Has Equivalent Outcomes to Percutaneous Transluminal Angioplasty and Stenting (PTA/Stent) in Patients with Severely Diseased Femoropopliteal Lesions: Justification to Leave Nothing
In-Kyong Kim1, Natalia N. Egorova2, James F. McKinsey1
1Surgery, New York-Presbyterian Hospital, Columbia University, New York, NY; 2Mount Sinai School of Medicine, New York, NY.

2:04 pm
RR9. Outpatient Office-based Endovascular Procedures are Safe and Effective: A 5-year Experience in Over 3,000 Cases
Samuel Ahn1, Monica J. Uceda1, Walter Kim2, Kenneth Kollmeyer1, Pablo Uceda1, Rhoda Leichter2, Craig Ferrara1, Todd Reil2, Robert Feldtman1, Joseph Caruso1, Karen McQuade1
1DFW Vascular Group, Dallas, TX; 2University Vascular Associates, Los Angeles, CA.

2:07 pm
RR10. Early Quantitative Evaluation of Indocyanine Green Angiography in Patients with Critical Limb Ischemia
Jonathan D. Braun, Magdiel Trinidad-Hernandez, Diana Perry, David G. Armstrong, Joseph L. Mills
University of Arizona, Tucson, AZ.

2:10 pm
Discussion: RR6, RR7, RR8, RR9, RR10

2:20 pm
RR11. Imaging Predictors of Cranial Nerve Injury in Carotid Body Tumor Resections
Adam H. Power, Thomas C. Bower, Terri J. Vrtiska, Audra A. Duncan, Manju Kalra, Gustavo S. Oderich, Peter Gloviczki
Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.

2:23 pm
RR12. CT Angiography-derived Duplex Ultrasound Velocity Criteria in Patients with Carotid Artery Stenosis
Adam J. Doyle, Jonathon J. Stone, Anthony Carnicelli, Sean J. Hislop, Michael J. Singh, Jason Kim, Jennifer Ellis, Nicholas J. Gargiulo, Ankur Chandra, David L. Gillespie
University of Rochester Medical Center, Rochester, NY.

2:26 pm
RR13. Statin Therapy After Infrainguinal Bypass Surgery for Critical Limb Ischemia is Associated with Improved Five-year Survival
Bjoern D. Suckow1, Larry W. Kraiss1, Andres Schanzer3, David H. Stone2, Jeffrey Kalish4, Randall R. DeMartino2, Jack L. Cronenwett2, Philip P. Goodney2
1University of Utah School of Medicine, Salt Lake City, UT; 2Dartmouth Medical School, Hanover, NH; 3University of Massachusetts Medical School, Worcester, MA; 4Boston University School of Medicine, Boston, MA.

2:29 pm
Discussion: RR11, RR12, RR13

1:30 pm – 5:45 pm           E1: RPVI Exam Preparation: Ultrasound Physics and Case-based Clinical 
                                        Content Review (1st Half)
                                        Room: Maryland 1-3

At the end of this session, participants should be able to:

  1. Demonstrate advanced interpretation skills for various noninvasive vascular tests.
  2. Describe normal and abnormal spectral Doppler waveforms from the major vessels.
  3. Identify various ultrasound artifacts.
  4. Comprehend ultrasound physics principles.
  5. Determine content areas in need of additional review.

Moderators: Steven A. Leers MD RVT, University of Pittsburgh Medical Center, Pittsburgh, PA
Ann Marie Kupinski PhD RVT RDMS FSVU, Albany Medical College, Albany, NY
Frank Miele MSEE, Pegasus Lectures, Inc., Forney, TX

1:30 pm
Welcome and Course Introduction
Ann Marie Kupinski PhD RVT RDMS FSVU, Albany Medical College, Albany, NY

1:35 pm
Cerebrovascular Testing Criteria
Steven A. Leers MD RVT, University of Pittsburgh Medical Center, Pittsburgh, PA

1:50 pm
Cerebrovascular Cases
Steven A. Leers MD RVT, University of Pittsburgh Medical Center, Pittsburgh, PA
Ann Marie Kupinski PhD RVT RDMS FSVU, Albany Medical College, Albany, NY

2:35 pm
Peripheral Venous Testing Criteria
Steven A. Leers MD RVT, University of Pittsburgh Medical Center, Pittsburgh, PA

2:50 pm
Peripheral Venous Cases
Steven A. Leers MD RVT, University of Pittsburgh Medical Center, Pittsburgh, PA
Ann Marie Kupinski PhD RVT RDMS FSVU, Albany Medical College, Albany, NY

3:30 pm
Break

3:45 pm
Peripheral Arterial Testing Criteria
Dennis F. Bandyk MD FACS, University of California – San Diego School of  Medicine, La Jolla, CA

4:00 pm
Peripheral Arterial Cases
Dennis F. Bandyk MD FACS, University of California – San Diego School of  Medicine, La Jolla, CA
Marsha M. Neumyer BS, RVT, FSVU, FSDMS, FAIUM, Vascular Diagnostic Educational Services, Harrisburg, PA

4:45 pm
Abdominal Vascular Testing Criteria
Dennis F. Bandyk MD, FACS, University of California – San Diego School of  Medicine, La Jolla, CA

5:00 pm
Abdominal Vascular Cases
Dennis F. Bandyk MD FACS, University of California – San Diego School of  Medicine, La Jolla, CA
Marsha M. Neumyer BS RVT FSVU FSDMS FAIUM, Vascular Diagnostic Educational Services, Harrisburg, PA

5:45 pm
RPVI (1st Half) Adjourns

2:35 pm – 3:30 pm           L1: Late-breaking Clinical Trial Session
                                        Room: Potomac A/B

At the end of this session, participants should be able to:

  1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
  2. Identify new technology for diagnosis and treatment of vascular disease.

Moderators: Peter Gloviczki MD, Mayo Clinic, Rochester, MN
Robert Y. Rhee MD, Lutheran Medical Center, Brooklyn, NY

2:35 pm
LB1: International Pivotal Controlled Clinical Trial of TEVAR with the TX2: Five-year Results
Jon S. Matsumura MD1, Germano Melissano MD2, Richard P. Cambria MD3, Michael D. Dake4, Shraddha Mehta MD5, Lars Svensson MD6
1University of Wisconsin, Madison , WI; 2San Raffaele Hospital, Milan, Italy; 3Massachusetts General Hospital, Boston, MA; 4Stanford University , Palo Alto, CA; 5MED Institute , West Lafayette, IN; 6Cleveland Clinic Foundation, Cleveland, OH.
 
2:42 pm
LB2. The Pythagoras U.S. Clinical Trial of the Aorfix Endograft for Endovascular AAA Repair (EVAR) With Highly-angulated Aortic Necks
Mark F. Fillinger MD, for the Pythagoras Investigators
Dartmouth-Hitchcock Medical Center, Lebanon, NH.
 

2:49 pm
LB3. Relay™ Thoracic Stent‐Graft Phase II PMA Submission Results
Mark A. Farber MD1, W. Anthony Lee MD2, Patrick Vaccaro MD3, Christopher Kwolek MD4, Gustavo Oderich MD5, Matthew Eagleton MD6, and Phillip Hess MD7, on behalf of the Bolton Relay Investigators
1University of North Carolina, Chapel Hill, NC; 2Christine E. Lynn Heart and Vascular Institute, Boca Raton FL; 3Ohio State University, Columbus, OH; 4Massachusetts General Hospital, Boston, MA; 5Mayo Clinic, Saint Mary’s Hospital, Rochester, MN; 6Cleveland Clinic Foundation, Cleveland, OH; and 7University of Florida, Gainsville, FL.

2:56 pm
LB4. Conformable TEVAR for Treatment of Acute Complicated Type B Aortic Dissection (cTBD): Multicenter Clinical Trial (TAG 08-01)
Richard P. Cambria MD1, Alan H. Matsumoto2, Mark F. Fillinger MD3, Alberto Pochettino MD4
1Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA; 2Department of Radiology, University of Virginia School of Medicine, Charlottesville, VA; 3Vascular Surgery Training Programs, Dartmouth-Hitchcock Medical Center, Lebanon, NH; 4University of Pennsylvania School of Medicine, Philadelphia, PA.

3:03 pm
LB5. One Year Results from the Zenith® Low Profile Pivotal AAA Endovascular Graft Clinical Study
Ronald M. Fairman MD1, Cherrie Abraham MD2, Stephan Haulon MD3, Satish C. Muluk MD4, Takao Ohki MD5, Michael J. Singh MD6, Benjamin W. Starnes MD7, Edward Y. Woo MD1, and Alan Saunders8 for the Zenith Low Profile Investigators
1Hospital of the University of Pennsylvania, 2Jewish General Hospital, 3HôpitalCardiologique, CHRU de Lille, 4Allegheny General Hospital, 5Jikei University Hospital, 6University of Rochester, 7University of Washington, 8MED Institute, Inc.

3:10 pm
LB6. Long-term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm
Frank A. Lederle MD1, Julie A. Freischlag MD2, Tassos C. Kyriakides PhD3 for the Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group
1Veterans Affairs Medical Center, Minneapolis, MN; 2Veterans Affairs Medical Center, Baltimore, MD; 3Veterans Affairs Medical Center, West Haven, CT

3:17 pm
LB7. Stem Cell Mobilization to Treat Severe Peripheral Artery Disease (STEMPAD)
Eric T. Choi MD1, Patrick Geraghty MD2, Christine Cooke MD2, Kenneth Schechtman MD2, Daniel Link MD2, Christopher M. Chambers MD3, Ravi K. Veeraswamy MD4
1Surgery, Temple University, Philadelphia, PA; 2Washington University, St. Louis, MO; 3Spectrum Health , Grand Rapids, MI;  4Emory University, Atlanta, GA 

3:30 pm – 5:00 pm           R2: Rapid Paced Paper Session II
                                        Room: Potomac A/B

At the end of this session, participants should be able to:

  1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
  2. Identify new technology for diagnosis and treatment of vascular disease.
Moderators: Richard P. Cambria MD, Massachusetts General Hospital, Boston, MA
Julie Ann Freischlag MD, Johns Hopkins University School of Medicine, Baltimore MD

3:30 pm
RR14. Spinal Cord Injury After Hybrid Endovascular Repair of Thoracoabdominal Aortic Aneurysms in the North American Complex Abdominal Aortic Debranching (NACAAD) Registry
Gustavo S. Oderich1, Carlos Timaran2, Mark Farber3, William Quinones-Baldrich4, Guillermo Escobar5, Peter Gloviczki1, Roy K. Greenberg6, James Black7, Sharif Ellozy8, Edward Woo9, Michael Singh10, Mark Fillinger11, Jason Lee12, Hasan H. Dosluoglu13
1Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN; 2University of Texas SouthWestern, Dallas, TX; 3University of North Carolina, Chapel Hill, NC; 4University of California Los Angeles, Los Angeles, CA; 5University of Michigan, Ann Arbor, MI; 6The Cleveland Clinic, Cleveland, OH; 7Johns Hopkins Medical Center, Baltimore, MD; 8Mount Sinai School of Medicine  ̶ New York, NY; 9University of Pennsylvania Medical Center, Philadelphia, PA; 10University of Rochester Medical Center, Rochester, NY; 11Dartmouth-Hitchcock Medical Center, Lebanon, NH; 12Stanford University Medical Center, Stanford, CA; 13State University of New York Buffalo, Buffalo, NY.

3:33 pm
RR15. Multilayer Flow Modulator Stents (MFM) as a Therapeutic Option in the Management of Thoraco-abdominal Aortic Aneurysms
Sherif Sultan1, Niamh Hynes2, Wael Tawfick1
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland; 2Galway Clinic, Galway, Ireland.

3:36 pm
RR16. Branched-fenestrated and Chimney-type Endovascular Repairs for Juxtarenal and Thoracoabdominal Aortic Aneurysms
Mark Fillinger
Dartmouth-Hitchcock Medical Center, Lebanon, NH.

3:39 pm
RR17. Optimal Selection of Patients for Elective Abdominal Aortic Aneurysm Repair Based on Life Expectancy
Randall R. De Martino1, Philip P. Goodney1, Brian W. Nolan1, William P. Robinson2, Alik Farber3, Jens Eldrup-Jorgensen4, Robert Cambria5, David H. Stone1, Jack L. Cronenwett1, For the Vascular Study Group of New England1
1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; 2University of Massachusetts Memorial Medical Center, Worcester, MA; 3Boston Medical Center, Boston, MA; 4Maine Medical Center, Portland, ME; 5Eastern Maine Medical Center, Bangor, ME.

3:42 pm
RR18. Helical Endostaple Fixation Blunts Aortic Neck Dilatation After Endovascular Aortic Aneurysm Repair
Wadi Gomero-Cure1, Manish Mehta2, Ronald M. Fairman3, John P. Henretta4, Marc H. Glickman5, David H. Deaton6
1Washington Hospital Center / Georgetown University Hospital, Washington DC; 2Albany Medical College, Albany, NY; 3Hospital of the University of Pennsylvania, Philadelphia, PA; 4Carolina Vascular, Asheville, NC; 5Sentara Norfolk General Hospital, Norfolk, VA; 6Georgetown University Hospital, Washington DC.

3:45 pm
Discussion: RR14, RR15, RR16, RR17, RR18

3:55 pm
RR19. Remodeling of Aortic Aneurysm and Aortic neck on Mid- and Long-term Follow-up After Endovascular Repair with Suprarenal Fixation
Nikolaos Tsilimparis, Anand Dayama, Joseph J. Ricotta
Department of Surgery, Division of Vascular Surgery, Emory University School of Medicine, Atlanta, GA.

3:58 pm
RR20. Inflammatory Response Following Endovascular Treatment of Abdominal Aortic Aneurysm: Impact of Endograft Type
Konstantinos G. Moulakakis1, Maria Alepaki2, Giorgos S. Sfyroeras1, Triantafillos G. Giannakopoulos1, Constantinos N. Antonopoulos1, John Kakisis1, Anastasios Papapetrou1, Petros Karakitsos2, Christos D. Liapis1
1Department of Vascular Surgery, University of Athens, Attikon Hospital, Greece, Athens, Greece; 2Department of Cytopathology, University of Athens, Attikon Hospital, Greece, Athens, Greece.

4:01 pm
RR21. Inflammatory Mediators and Cerebral Embolism in Carotid Stenting: New Markers of Risk
Gianluca Faggioli, Rodolfo Pini, Silvia Fittipaldi, Gianandrea Pasquinelli, Caterina Tonon, Elisabetta Beltrandi, Raffaella Mauro, Andrea Stella
Vascular Surgery, University of Bologna, Italy, Bologna, Italy.

4:04 pm
RR22. Magnetic Resonance Imaging for Identifying Vulnerable Carotid Plaques
Antoine Millon1, Jean-Louis Mathevet1, Loic Boussel1, Zahi Fayad2, Peter Faries2, Patrick Feugier1, Philippe Douek1
1University Hospital of Lyon, France, Lyon, France; 2Mount Sinai Hospital, New York, NY.

4:07 pm
RR23. A Stroke/Vascular Neurology Service Increases the Volume of Urgent CEAs Performed in a Tertiary Referral Center
Hernan A. Bazan, Gentry Caton, Sharzad Talebinejad, Ross Hoffman, Taylor Smith, Elizabeth Holt, Gabriel Vidal, Kenneth Gaines, W Charles Sternbergh III
Ochsner Clinic, New Orleans, LA.

4:10 pm
Discussion: RR19, RR20, RR21, RR22, RR23

4:20 pm
RR24. Fate of Patients with Spinal Cord Ischemia (SCI) Complicating Thoracic Endovascular Aortic Repair (TEVAR)
Kenneth DeSart, Salvatore T. Scali, Michael Hong, Robert J. Feezor, Thomas S. Huber, Adam W. Beck
University of Florida, Gainesville, FL.

4:23 pm
RR25. Outcomes Following Late Explantation of Aortic Endografts Depend on the Indication
Shipra Arya1, Dawn M. Coleman1, Jordan Knepper1, Peter K. Henke1, Gilbert R. Upchurch2, John E. Rectenwald1, Enrique Criado1, Jonathan L. Eliason1, Katherine Gallagher1
1Vascular Surgery, University of Michigan, Ann Arbor, MI; 2University of Virginia, Charlottesville, VA.

4:26 pm
RR26. Primary Balloon Angioplasty of Small (≤2 mm) Cephalic Veins Shortens Maturation Time, Decreases Reinterventions and Improves Mid-term Patency of Arteriovenous Fistulae
Pierfrancesco Veroux1, Tiziano Tallarita1, Alessia Giaquinta1, Peter Gloviczki2, Massimiliano Veroux1
1Policlinico of Catania, Catania, Italy; 2Mayo Clinic, Rochester, MN.

4:29 pm
RR27. Predictors of Maturation After a Native First Arteriovenous Fistula Creation
Yang Jin Park, Shin Suk Yang, Keun Myung Park, Dong-Ik Kim, Young-Wook Kim
Samsung Medical Center, Seoul, Republic of Korea.

4:32 pm
RR28. Intermediate Results of a Non-operative Management Strategy for Blunt Thoracic Aortic Injuries
John W. York, Ginger L. Manos, Brent L. Johnson, Chris G. Carsten, Spence M. Taylor, David L. Cull, Bryan C. Morse, Stephen C. Lowe
Surgery, University Medical Center-Greenville Hospital System, Greenville, SC.

4:35 pm
Discussion: RR24, RR25, RR26, RR27, RR28

4:45 pm
RR29. Intravascular Ultrasound: A Critical Tool for Accurate Endograft Sizing in Blunt Traumatic Aortic Injury
Nam T. Tran, Gabriel Wallace, Michael Sobel, Benjamin W. Starnes, Thomas Hatsukami
Division of Vascular Surgery, University of Washington, Seattle, WA.

4:48 pm
RR30. Prediction of Post-discharge Venous Thromboembolism: A Risk Assessment Model to Guide Decision Making in Post-discharge Thromboprophylaxis
James C. Iannuzzi, Kate C. Young, Michael J. Kim, John R. Monson, Fergal J. Fleming
University of Rochester, Rochester, NY.

4:51 pm
RR31. Ambulatory Venous Thrombectomy for Acute Deep Venous Thrombosis
Jeffrey Y. Wang1, Naren Gupta2, Joseph D. Raffetto2, Shan-Ali Haider1, Richard Silva1, James L. Ebaugh2, Michael Sulkin1, Robert Fox1
1Shady Grove Adventist Hospital, Rockville, MD; 2VA Boston Healthcare System, Boston, MA.

4:54 pm
Discussion: RR29, RR30, RR31

5:00 pm
2012 Vascular Annual Meeting Adjourns

Posted May 2012

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

Follow Us

YouTube

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.